Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

TEntrada Therapeutics, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
T

Entrada Therapeutics, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions
Loading insider transactions

Insider transactions

Insider sentiment

Insider transactions

Insider sentiment

SellBuy
DateNameTitleSharesValueTransactionSource
Sep 9, 2026MPM BioVentures 2014, L.P.10% Owner28,837Common Stock—Sell
Sep 9, 2026MPM BIOVENTURES 2018, L.P.10% Owner28,837Common Stock—Sell
Sep 8, 2026MPM BioVentures 2014, L.P.10% Owner192,500Common Stock—Sell
Sep 8, 2026MPM BIOVENTURES 2018, L.P.10% Owner192,500Common Stock—Sell
Sep 4, 2026MPM BioVentures 2014, L.P.10% Owner38,500Common Stock—Sell
Sep 4, 2026MPM BIOVENTURES 2018, L.P.10% Owner38,500Common Stock—Sell
Sep 3, 2026MPM BioVentures 2014, L.P.10% Owner32,263Common Stock—Sell
Sep 3, 2026MPM BIOVENTURES 2018, L.P.10% Owner32,263Common Stock—Sell
Sep 2, 2026MPM BioVentures 2014, L.P.10% Owner25,131Common Stock—Sell
Sep 2, 2026MPM BIOVENTURES 2018, L.P.10% Owner25,131Common Stock—Sell
…
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • Insider Transactions